Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
268M
-
Shares change
-
+22.1M
-
Total reported value, excl. options
-
$3.35B
-
Value change
-
+$271M
-
Put/Call ratio
-
0.93
-
Number of buys
-
129
-
Number of sells
-
-67
-
Price
-
$12.48
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q2 2019
254 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q2 2019.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 268M shares
of 309M outstanding shares and own 86.93% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (22.8M shares), VANGUARD GROUP INC (22.3M shares), PERCEPTIVE ADVISORS LLC (21.5M shares), BlackRock Inc. (18.6M shares), JANUS HENDERSON GROUP PLC (10.9M shares), Avoro Capital Advisors LLC (10M shares), STATE STREET CORP (9.8M shares), WELLINGTON MANAGEMENT GROUP LLP (8.31M shares), JENNISON ASSOCIATES LLC (7.86M shares), and Palo Alto Investors LP (7.8M shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.